GSK Pharma gets court decree demanding Rs 38.06 cr over old premises case
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Midcap 150 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GSK Pharma received a court decree from Court of Small Causes Bombay dated May 6, 2025, demanding Rs 38.06 crores. The decree relates to mesne profit for office premises used by Burroughs Wellcome India (a predecessor entity merged with GSK) from June 2001. It includes Rs 87.09 lakhs principal and Rs 37.19 crores in simple interest at 9%. The matter is over 24 years old. The company is evaluating the decree and plans to file an appeal to challenge it.
Rs 38.06 cr court order against GSK Pharma from a 24-year-old premises case; company plans to appeal. Likely limited financial impact given company size.